"Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or Mini Strokes"

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 25, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Thrombosis
Interventions
DRUG

BMS-986141

DRUG

Aspirin

OTHER

Placebo

Trial Locations (33)

17403

York Hospital, York

19104

Hospital of the University of Pennsylvania, Philadelphia

19718

Local Institution, Newark

21215

Local Institution, Baltimore

26505

West Virginia University, Morgantown

27405

Guilford Medical Associates, Pa, Greensboro

27599

Local Institution, Chapel Hill

27710

Duke University Medical Center, Durham

29425

Medical University Of South Carolina, Charleston

32209

University Of Florida Hsc/Jacksonville, Jacksonville

32610

University Of Florida, Gainesville

32803

Florida Hospital, Orlando

34239

Intercoastal Medical Group, Sarasota

38103

Local Institution, Memphis

40202

University Of Louisville, Louisville

59405

Advanced Neurology Specialists, Great Falls

64035

Presence Saint Joseph Medical Center, Joliet

64111

St. Lukes Marion Bloch Neuroscience Institute, Kansas City

68105

Local Institution, Omaha

85006

Banner University Medical Ctr, Phoenix

92658

Hoag Memorial Hospital, Newport Beach

97225

Providence Portland Med Ctr, Portland

Providence St Vincent Medical Center, Portland

97239

Oregon Health Science Univ, Portland

3501298

Local Institution, Hidaka-shi

4600001

Local Institution, Nagoya

6500047

Local Institution, Kobe

02111

Tufts Medical Center, Boston

02118

Boston Medical Center, Boston

08820-3947

JFK Medical Center, Edison

0608570

Local Institution, Sapporo

982-8523

Local Institution, Sendai

810-0001

Local Institution, Fukuoka

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY